ANDA 84721, held by Carlisle. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 84721 (Alphacaine Hydrochloride), held by Carlisle, was first approved by FDA on Oct 7, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 7, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alphacaine Hydrochloride2% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters